全文获取类型
收费全文 | 6037篇 |
免费 | 559篇 |
国内免费 | 42篇 |
学科分类
医药卫生 | 6638篇 |
出版年
2023年 | 31篇 |
2022年 | 15篇 |
2021年 | 126篇 |
2020年 | 82篇 |
2019年 | 180篇 |
2018年 | 204篇 |
2017年 | 166篇 |
2016年 | 186篇 |
2015年 | 234篇 |
2014年 | 270篇 |
2013年 | 335篇 |
2012年 | 445篇 |
2011年 | 475篇 |
2010年 | 298篇 |
2009年 | 280篇 |
2008年 | 328篇 |
2007年 | 299篇 |
2006年 | 354篇 |
2005年 | 262篇 |
2004年 | 263篇 |
2003年 | 236篇 |
2002年 | 203篇 |
2001年 | 154篇 |
2000年 | 143篇 |
1999年 | 116篇 |
1998年 | 47篇 |
1997年 | 45篇 |
1996年 | 36篇 |
1995年 | 21篇 |
1994年 | 26篇 |
1993年 | 27篇 |
1992年 | 73篇 |
1991年 | 74篇 |
1990年 | 58篇 |
1989年 | 63篇 |
1988年 | 38篇 |
1987年 | 38篇 |
1986年 | 48篇 |
1985年 | 35篇 |
1984年 | 30篇 |
1983年 | 33篇 |
1982年 | 24篇 |
1981年 | 22篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 16篇 |
1975年 | 14篇 |
1974年 | 30篇 |
1973年 | 21篇 |
1972年 | 18篇 |
排序方式: 共有6638条查询结果,搜索用时 15 毫秒
1.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
2.
3.
4.
5.
6.
Activity and Toxicity of Eleutherine palmifolia (L.) Merr. Extract on BALB/c Mice Colitis-Associated Colon Cancer Model 下载免费PDF全文
Roihatul MutiahRiza Ambar SariWahyi Yucha FirsyaradhaAnik ListiyanaYen Yen Ari IndrawijayaAbdul WafiArief SuryadinataRetno SusilowatiAna Rahmawati 《Asian Pacific journal of cancer prevention》2020,21(12):3579-3586
Objective: Eleutherine palmifolia (L.) Merr. extract (EPE) containing isoliquiritigenin and oxyresveratrol is believed to be an anticancer agent. This study evaluates colon histopathology, TNF-α, TGF-β, and hepatotoxicity on BALB/c mice colitis-associated colon cancer (CAC) model treated with EPE. Methods: In vivo study was performed on BALB/c mice CAC model induced by 10 mg/kgBW AOM on the first day followed by administration that each cycle consisted of 5% DSS in water for seven days and regular water for seven days. The indicators of the formation of CAC were observed by a fecal occult blood test (FOBT) and serum amyloid α (SAA) test. The treatment was conducted once a week started from the seventh week up to the twentieth week with six treatment groups: I was administrated by regular water only (negative control), II was administrated by AOM and DSS only (positive control), III was administrated by doxorubicin, IV-VI were treated by EPE (0.25 mg/kg BW, 0.50 mg/kg BW, and 1.00 mg/kg BW) respectively. The colon and liver’s histopathology was observed using hematoxylin-eosin (HE) staining, TNF-α with immunohistochemistry (IHC), and level measurement of TGF-β colon with ELISA reader. The data were used one-way ANOVA followed by post hoc as statistical analysis. Results: The administration of EPE increased the expression of TNF-α, the total of goblet cells of the colon, and decreased the level of TGF-β. Administration of EPE 0.50 mg/20g BW decreased a liver histopathological score but induced a histopathological alteration of the liver at a dose of 1.00 mg/20g BW. Conclusion: This study indicate that EPE could be recommended as a colon anticancer through increase the goblet cells, induce apoptosis through increase TNF-α, and decrease TGF-β. 相似文献
7.
8.
Kuo-Ping Shen Chi-Long Hao Hsueh-Wei Yen Chun-Yen Chen Bin-Nan Wu Hui-Li Lin 《Journal of Clinical Biochemistry and Nutrition》2015,56(1):28-34
This study investigated the effect and mechanism of pre-germinated brown rice (PGBR) prevented hyperglycemia in C57BL/6J mice fed high-fat-diet (HFD). Normal six-week-old mice were randomly divided into three groups. Group 1 was fed standard-regular-diet (SRD) and group 2 was fed HFD for 16 weeks. In group 3, the mice were fed a HFD with its carbohydrate replaced with PGBR for 16 weeks. Comparing the SRD and HFD groups, we found the HFD group had higher blood pressure, higher concentrations of blood glucose and HbA1c. The HFD group had less protein expression of insulin receptor (IR), insulin receptor substrate-1 (IRS-1), phosphatidylinositol-3-kinase (PI3K), glucose transporter-4 (GLUT-4) and glucokinase (GCK) and greater expression of glucogen synthase kinase (GSK) in skeletal muscle. The HFD group also had less expression of IR, serine/threonine kinase PI3K-linked protein kinase B (Akt/PKB), AMP-activated protein kinase (AMPK), GCK and peroxisome proliferator-activated receptor γ (PPARγ) in liver. In the HFD + PGBR group, the PGBR could reverse the disorders of blood pressure, blood glucose, HbA1c and increase insulin concentration. PGBR increased the IR, IRS-1, PI3K, Akt, GLUT-1 and GLUT-4 proteins, and ameliorated AMPK, GCK, GSK and PPARγ proteins. Together, PGBR prevented HFD-induced hyperglycemia through improving insulin levels, insulin receptor, glucose transporters and enhancing glucose metabolism. 相似文献
9.